Céline Pallaud

Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial

David Cameron, Julia Brown, Rebecca Dent et al. · The Lancet Oncology · 2013 · 432 citations

Adjuvant Bevacizumab-containing Therapy, Breast Oncology, Medicine +7

Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial

Michael R. Migden, Alexander Guminski, Ralf Gutzmer et al. · The Lancet Oncology · 2015 · 419 citations

Surgical Oncology, Medicine, Metronomic Therapy +6

AVEREL: A Randomized Phase III Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER2-Positive Locally Recurrent/Metastatic Breast Cancer

Luca Gianni, Gilles Romieu, Sérgio Serrano et al. · Journal of Clinical Oncology · 2013 · 255 citations · Full text

First-line Therapy, Breast Oncology, Medicine +13

A Multilocus Genotyping Assay for Candidate Markers of Cardiovascular Disease Risk

Suzanne Cheng, Michael Grow, Céline Pallaud et al. · Genome Research · 1999 · 207 citations · Full text

Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia

Konstanze Döhner, Christian Thiede, Nikolaus Jahn et al. · Blood · 2019 · 188 citations · Full text